108 related articles for article (PubMed ID: 9602356)
1. Somatic hypermutation in mouse lambda chains.
Azuma T
Immunol Rev; 1998 Apr; 162():97-105. PubMed ID: 9602356
[TBL] [Abstract][Full Text] [Related]
2. A lambda 1 transgene under the control of a heavy chain promoter and enhancer does not undergo somatic hypermutation.
Hengstschläger M; Williams M; Maizels N
Eur J Immunol; 1994 Jul; 24(7):1649-56. PubMed ID: 8026525
[TBL] [Abstract][Full Text] [Related]
3. Comparison of somatic mutation frequency among immunoglobulin genes.
Motoyama N; Miwa T; Suzuki Y; Okada H; Azuma T
J Exp Med; 1994 Feb; 179(2):395-403. PubMed ID: 8294856
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutation in constant regions of mouse lambda 1 light chains.
Motoyama N; Okada H; Azuma T
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7933-7. PubMed ID: 1910169
[TBL] [Abstract][Full Text] [Related]
5. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes.
Johnston JM; Ihyer SR; Smith RS; Tai KF; Farmer T; Korsmeyer SJ; Nadon NL; Carroll WL
Eur J Immunol; 1996 May; 26(5):1058-62. PubMed ID: 8647167
[TBL] [Abstract][Full Text] [Related]
6. Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer.
Klotz EL; Storb U
J Immunol; 1996 Nov; 157(10):4458-63. PubMed ID: 8906822
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the chloramphenicol acetyl transferase transgene driven by the immunoglobulin promoter and intron enhancer.
Azuma T; Motoyama N; Fields LE; Loh DY
Int Immunol; 1993 Feb; 5(2):121-30. PubMed ID: 8452812
[TBL] [Abstract][Full Text] [Related]
8. Genetic basis for altered idiotype expression in the hyperimmune response to (4-hydroxy-3-nitrophenyl)acetyl hapten.
White-Scharf ME; Imanishi-Kari T
J Immunol; 1986 Aug; 137(3):887-96. PubMed ID: 3088116
[TBL] [Abstract][Full Text] [Related]
9. Hypermutation is observed only in antibody H chain V region transgenes that have recombined with endogenous immunoglobulin H DNA: implications for the location of cis-acting elements required for somatic mutation.
Giusti AM; Manser T
J Exp Med; 1993 Mar; 177(3):797-809. PubMed ID: 8436910
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the role of the 3'alpha heavy chain enhancer [3'alpha E(hs1,2)] in Vh gene somatic hypermutation.
Tumas-Brundage KM; Vora KA; Manser T
Mol Immunol; 1997 Apr; 34(5):367-78. PubMed ID: 9293770
[TBL] [Abstract][Full Text] [Related]
11. Antibody repertoires of four- and five-feature translocus mice carrying human immunoglobulin heavy chain and kappa and lambda light chain yeast artificial chromosomes.
Nicholson IC; Zou X; Popov AV; Cook GP; Corps EM; Humphries S; Ayling C; Goyenechea B; Xian J; Taussig MJ; Neuberger MS; Brüggemann M
J Immunol; 1999 Dec; 163(12):6898-906. PubMed ID: 10586092
[TBL] [Abstract][Full Text] [Related]
12. Ongoing somatic hypermutation of the rearranged VH but not of the V-lambda gene in EBV-transformed rheumatoid factor-producing lymphoblastoid cell line.
Chezar I; Lobel-Lavi L; Steinitz M; Laskov R
Mol Immunol; 2008 Nov; 46(1):80-90. PubMed ID: 18718665
[TBL] [Abstract][Full Text] [Related]
13. The amino acid residue at position 95 and the third CDR region in the H chain determine the ceiling affinity and the maturation pathway of an anti-(4-hydroxy-3-nitrophenyl)acetyl antibody.
Murakami A; Takahashi Y; Nishimura M; Shimizu T; Azuma T
Mol Immunol; 2010; 48(1-3):48-58. PubMed ID: 20961619
[TBL] [Abstract][Full Text] [Related]
14. Somatic variants of murine immunoglobulin lambda light chains.
Bothwell AL; Paskind M; Reth M; Imanishi-Kari T; Rajewsky K; Baltimore D
Nature; 1982 Jul; 298(5872):380-2. PubMed ID: 6283385
[TBL] [Abstract][Full Text] [Related]
15. B cell selection and affinity maturation during an antibody response in the mouse with limited B cell diversity.
Kanayama N; Kimoto T; Todo K; Nishikawa Y; Hikida M; Magari M; Cascalho M; Ohmori H
J Immunol; 2002 Dec; 169(12):6865-74. PubMed ID: 12471119
[TBL] [Abstract][Full Text] [Related]
16. A lambda 3' enhancer drives active and untemplated somatic hypermutation of a lambda 1 transgene.
Kong Q; Zhao L; Subbaiah S; Maizels N
J Immunol; 1998 Jul; 161(1):294-301. PubMed ID: 9647236
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutation of immunoglobulin lambda chains: a segment of the major intron hypermutates as much as the complementarity-determining regions.
González-Fernández A; Gupta SK; Pannell R; Neuberger MS; Milstein C
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12614-8. PubMed ID: 7809087
[TBL] [Abstract][Full Text] [Related]
18. Production and immunoselection of IgM-IgA hybridomas: preparing immunoglobulins with dual binding specificity.
Ju ST; Strack P; Dorf ME
Mol Immunol; 1989 Mar; 26(3):283-92. PubMed ID: 2495437
[TBL] [Abstract][Full Text] [Related]
19. Subtle differences in antibody responses and hypermutation of lambda light chains in mice with a disrupted chi constant region.
Zou X; Xian J; Popov AV; Rosewell IR; Müller M; Brüggemann M
Eur J Immunol; 1995 Aug; 25(8):2154-62. PubMed ID: 7664778
[TBL] [Abstract][Full Text] [Related]
20. BASH-deficient mice: limited primary repertoire and antibody formation, but sufficient affinity maturation and memory B cell generation, in anti-NP response.
Yamamoto M; Nojima T; Hayashi K; Goitsuka R; Furukawa K; Azuma T; Kitamura D
Int Immunol; 2004 Aug; 16(8):1161-71. PubMed ID: 15237108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
